Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 4/20 | 0.42 |
| ▸ | RAB9A | P51151 | 4/20 | 0.42 |
| ▸ | CNR1 | P21554 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7057635 | 0.79 | EPHX1 (0.51) | KMT2APOLBLMNAGAAHTT | |
| SCHEMBL8219616 | 0.73 | KMT2A (0.65) | KMT2APOLBLMNAGAAHTT | |
| SCHEMBL1952759 | 0.72 | LMNA (0.63) | KMT2APOLBLMNAGAAHTT | |
| SCHEMBL7054927 | 0.71 | CNR1 (0.43) | KMT2APOLBLMNAGAAHTT | |
| SCHEMBL13801231 | 0.70 | LMNA (0.62) | KMT2APOLBLMNAGAAHTT | |
| SCHEMBL22803038 | 0.70 | MEN1 (0.51) | KMT2ALMNACYP1A2CYP2D6CYP2C19 | |
| SCHEMBL7055022 | 0.69 | GAA (0.47) | KMT2APOLBLMNAGAAHTT | |
| SCHEMBL7740585 | 0.69 | GAA (0.44) | KMT2APOLBLMNAGAAHTT | |
| SCHEMBL7055824 | 0.68 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL7556339 | 0.67 | ALDH1A1 (0.38) | KMT2APOLBLMNAGAAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0970044-B1 | CYCLOALKYLALKANECARBOXAMIDES AND THE PRODUCTION AND USE THEREOF | BASF AG (DE) | 2003-05-07 | — | — | EP | disclosed |
| US-6410486-B2 | FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2002-06-25 | — | — | US | disclosed |
| US-20020019422-A1 | Cycloalkylalkanecarboxamides and their preparation and use | WETTERICH FRANK (DE) | 2002-02-14 | — | — | US | disclosed |
| US-6265447-B1 | FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2001-07-24 | — | — | US | disclosed |
| EP-0970044-A1 | CYCLOALKYLALKANECARBOXAMIDES AND THE PRODUCTION AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2000-01-12 | — | — | EP | disclosed |
| WO-1998041499-A1 | CYCLOALKYLALKANECARBOXAMIDES AND THE PRODUCTION AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 1998-09-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019422-A1 | Cycloalkylalkanecarboxamides and their preparation and use | CBR3, CYCS, CBR1 | KMT2A 2102/4885POLB 685/4885LMNA 1204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.